Company Involving High Tech, Life Sciences And Biotech

By Author: Raymond Sylvain
Total Articles: 9
Comment this article

Austrianova is one company that does deals that comprises high tech, life sciences and biotech. It is complemented with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science congregatedcombined organization that focuses in the indusion of living cells or bacteria in small tablets for defense which is also regarded as cell encapsulation technology, isolation, storage and transportation. We were first formed in the year 2007 and was based in Singapore's greatest research biotech hub, Biopolis that has large-scale dream in supporting encapsulation facilities like micro encapsulation.

There is a rapid moving topic of passion in healthy maintenance and more precise, in the topic of neutraceuticals which is the understanding and use of probiotic bacteria. Hence, probiotics encapsulation was developed. The cell-in-a-box technology was formed by Austranova with the aim to keep safe, cut off, store and transport living cells. This protective technology can be used for several reasons and can be operated to probiotics, cosmetics and agriculture environmental protection and monitoring ...
... as well as shaping the foundation of a influential study tool.

In healthcare, this knowledge assists run safe embedding of cells or stem cells such as cell therapy, holding them separated from the immune system and allowing long term making of therapeutic molecules in patients. In biotechnology, the cell-in-a-box procedure protects cells in bioreactors and fermentors and at the same time, it make easier cleansing of bioproducts formed from the cells and it cut down constructing charge too.

A huge gauge cGMP facility for the manufacturing of biomedical grade encapsulated cell products was beforehand successfully created and right now, Austrianova is in the process of setting up this skill in the whole of SE Asia. This means the use of cell-in-a-box was quite a success for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to allow minor doses of chemotherapy to be used more efficaciously without the common devastating side results. The encapsulated cell are situated, using supraselective catheterisation, into blood vessels that goes to the tumor where they locally change a chemotherapeutic product to its tumor toxic product.

Visit our website for more information: Capsules, Cell Therapy, Stem Cells.